全球表皮微流体诊断技术的进步和增长机会

Global Epifluidic Diagnostics Technology Advancements and Growth Opportunities

出版日期: 2023年07月26日 | 出版商:

Frost & Sullivan | 英文 58 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

灵活的微流体和电子颠覆性技术推动下一代设备的开发

这项研究服务探索表皮微流体诊断技术的进步，并揭示它们给医疗保健行业带来的增长机会。表皮微流体诊断是一种新型可穿戴诊断技术，可通过紧贴皮肤的微流体系统分析汗液和间质液 (ISF)。配备微电子、传感器和柔性微流体，穿戴在皮肤上的柔性微型设备可以长时间连续、无痛地采样替代生物流体，以进行精确的健康监测，可以对诊断对象进行连续实时监测。该领域的技术进步，特别是人工智能（AI）和机器学习（ML）解决方案的整合，将有助于提高诊断准确性并提高用户便利性。

研究人员发现，基于汗液和 ISF 的诊断可用于多种用途，包括病毒感染检测、囊性纤维化诊断、尿素监测和帕金森病管理。基于汗液的表皮微流诊断技术主要用于供给管理和物质使用检测，而基于ISF的表皮微流诊断技术用于代谢物检测。主要企业正在积极扩展基于 ISF 的表皮微流体诊断，以实现更多临床用途，例如治疗药物监测、心血管疾病监测和脓毒症检测。影响多个领域的表皮微流体诊断在未来几年具有巨大的市场潜力。

该报告全面涵盖了不同类型的表皮微流体诊断技术及其优势，以确定驱动和限制该市场增长的因素。它还确定了基于汗液的表皮微流体诊断和基于 ISF 的表皮微流体诊断的关键参与企业，并检验了它们的技术采用、目标用途和商业性准备水平。该研究还涵盖了资金筹措、併购和专利申请等区域和行业趋势。基准年为2022年，预测期为2023-2027年。

针对不同目标分析物的汗液和基于 ISF 的表皮微流体诊断的商业性可用性
表皮微流控诊断：多样化的应用和发展现状
表皮微流控诊断技术路线图
表皮微流控诊断装置发展的区域趋势
表皮微流控诊断器械行业併购分析（2020-2023年）
表皮微流诊断政府资助分析（2020-2023）
表皮微流体诊断私人资金筹措概况，2020-2023 年

专利分析

表皮微流控诊断知识产权活动分析（2018-2023）
基于汗液的表皮微流控诊断技术——创新主题分析（2018-2023）
基于ISF的表皮微流控诊断技术——创新主题分析（2018-2023）

充满增长机会的宇宙

增长机会 1：利用替代样品分析生物流体的新型微流体系统
增长机会2：物联网、AI/ML算法等先进资讯通讯技术
增长机会3：主要参与者、学术机构和政府之间的合作

附录

技术准备水平 (TRL)：解释
专利

下一步

下一步
为什么是霜冻，为什么是现在？
免责声明

简介目录

Product Code: DAB3

Disruptive technologies in flexible microfluidics and electronics are driving the development of next-generation devices

This research service examines the advancements in epifluidic diagnostics technology, identifying the growth opportunities they present for the healthcare industry. Epifluidic diagnostics is an emerging class of wearable diagnostics that enables sweat and interstitial fluid (ISF) analysis through skin-interfaced microfluidic systems. These body-worn skin-conformable and flexible miniature devices with microelectronics, sensors, and flexible microfluidics allow long-term, painless, and continuous sampling of the alternate biofluids and real-time and continuous monitoring of diagnostic targets for precise health management. Technology advancements in this field, particularly the integration of artificial intelligence (AI) and machine learning (ML) solutions, help enable higher diagnostics accuracy and enhanced user convenience.

Researchers have found evidence that sweat- and ISF-based diagnostics can be used for a diverse range of applications, including viral infection detection, cystic fibrosis diagnosis, urea monitoring, and Parkinson's disease management. Sweat-based epifluidic diagnostics are predominantly utilized for hydration management and substance-use detection, while ISF-based epifluidic diagnostics are employed for metabolite measurement. Key players are actively expanding ISF-based epifluidic diagnostics for more clinical uses, such as therapeutic drug monitoring, cardiovascular disease monitoring, and sepsis detection. With several sectors of impact, epifluidic diagnostics has high market potential in the coming years.

The report takes a comprehensive look at the different types of epifluidic diagnostic technologies and their benefits and identifies the factors driving and restraining the growth of this market. It also identifies the key participants in the sweat-based epifluidic diagnostics and ISF-based epifluidic diagnostics segments, examining the technologies they employ, their target applications, and commercial readiness levels. The study covers regional and industry trends, including funding rounds, mergers and acquisitions (M&A), and patents filed. The base year is 2022, and the forecast period is 2023 to 2027.

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Epifluidic Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Conventional Diagnostics and Epifluidic Diagnostics: A Comparison
Components of an Epifluidic Diagnostic Device and Emerging Innovations
Segmentation
Growth Drivers
Growth Restraints
Scope of Analysis

Technology Analysis: Sweat-based Epifluidic Diagnostics

Overview
Competitive Environment
Emerging Sweat-sensing Applications from the Academic Innovation Ecosystem

Technology Analysis: ISF-based Epifluidic Diagnostics

Overview
Competitive Environment
Emerging ISF-sensing Applications from the Academic Innovation Ecosystem

Innovation Indicators

Commercial Availability of Sweat- and ISF-based Epifluidic Diagnostics for Different Target Analytes
Epifluidic Diagnostics: Diverse Applications and Development Status
Technology Roadmap of Epifluidic Diagnostics
Regional Trends of Epifluidic Diagnostic Device Development
Analysis of M&As in the Epifluidic Diagnostics Industry, 2020-2023
Analysis of Government Funding for Epifluidic Diagnostics, 2020-2023
Snapshot of Private Funding for Epifluidic Diagnostics, 2020-2023

Patent Analysis

IP Activity Analysis on Epifluidic Diagnostics (2018-2023)
Sweat-based Epifluidic Diagnostics-Innovation Themes Analysis (2018-2023)
ISF-based Epifluidic Diagnostics-Innovation Themes Analysis (2018-2023)

Growth Opportunity Universe

Growth Opportunity 1: Novel Microfluidic Systems Analyzing Alternate Sampleable Biofluids
Growth Opportunity 2: IoT, AI/ML Algorithms, and Other Advanced Information and Communication Technologies
Growth Opportunity 3: Collaborations between Key Players, Academic Institutes, and Governments